Phasing In A New Chief Executive At Shire: An Interview With Angus Russell
After announcing his retirement as CEO of Shire, effective next April, Angus Russell held a wide-ranging discussion with “The Pink Sheet” to explain why he is stepping down and why now is a good time for change at the specialty pharma.
You may also be interested in...
Representatives from cardiac monitoring device manufacturers and professional societies are working together to persuade Medicare carrier Novitas to reconsider its payment rates for extended cardiac monitoring. See what Michael Coyle, iRhythm’s CEO, said about it here.
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.
During oral argument in the Arthrex case, several justices seemed to agree with the Federal Circuit that PTAB judges should have been appointed by the president. They could opt to get around the problem by enabling the PTO director to review all panel decisions.